SHH and metabolic dysfunction-associated steatotic liver disease: A transgenic mouse model was developed in which Shh is secreted from hepatocytes, which mimics histopathological features of patients with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) [113].